Remove latest
article thumbnail

STAT+: ‘Devalued, disempowered, and unseen’: Mass General Brigham doctors react to latest merger step

STAT

Mass General Brigham, a dominant force in Boston medicine, was launching the latest and perhaps most contentious step in its ongoing effort to merge its two flagship Harvard-affiliated medical centers: combine all departments and divisions at both hospitals in a move that executives argued would improve patient care and access.

Hospitals 293
article thumbnail

Opinion: What the public might learn from Kate Middleton, the latest ‘famous patient’

STAT

The latest entry is that of Catherine, the Princess of Wales, also known as Kate Middleton, who revealed she has cancer and is undergoing chemotherapy. As with her many of her predecessors, the princess’s story will likely both reveal and conceal, but I suspect it will ultimately both move and enlighten the public.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Listen: Covid’s latest surge, Alnylam at the FDA, & the end of an era

STAT

Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

328
328
article thumbnail

Latest data shows millions of eligible Americans have been disenrolled from Medicaid

STAT

More than 10 million people were disenrolled from Medicaid over the past six months, according to the latest data published by a KFF tracker.

362
362
article thumbnail

With latest tranche, U.K. Biobank has genome sequences from 500,000 people available for research

STAT

Biobank on Thursday debuted the latest addition to what it aims to be the world’s most comprehensive health data resource. LONDON — Data from half a million people’s whole genome sequences are now available to researchers worldwide, as the U.K.

article thumbnail

Listen: The plight of the VC, Gilead’s latest setback, & more M&A

STAT

We also take a look at Gilead Sciences’ struggle to turn itself into an oncology company and the latest biotech to get bought out by a major pharma firm. We discuss how biotech’s downturn has made life difficult not just for startups but also the VCs they rely on for much-needed funding. Read the rest…

256
256
article thumbnail

Novavax is on thin ice, and the latest update isn’t exactly encouraging

STAT

Damian here with the latest twist in biotech’s recovery, a close look at Bluebird Bio, and the uncertain future of a Covid-19 player. And the latest update isn’t exactly encouraging. Novavax won’t disclose its revenue until later this month, but its latest communications don’t exactly inspire confidence.